Biologics Research Review, Issue 79 – Dermatology focus
In this issue:
Adalimumab-induced paradoxical psoriasis treated with IL-17/IL-23 inhibitors
Do biologic treatments for psoriasis lower the risk of psoriatic arthritis?
Omalizumab in the treatment of bullous pemphigoid
Response to IL-17A inhibitors according to prior biologic exposures
Risk of paradoxical eczema with biologics for psoriasis
Dupilumab-associated lymphoid reactions in atopic dermatitis
Real-world effectiveness of risankizumab in moderate-to-severe psoriasis
Risk of infection in hidradenitis suppurativa patients on immunomodulators or biologics
Impacts of biologic treatment on metabolic profiling in psoriasis
Long-term use of upadacitinib for atopic dermatitis
Expert contributor
Associate Professor Annika Smith
Dr Annika Smith is a Fellow of the Australasian College of Dermatologists and Consultant Dermatologist in public and private settings in Sydney. Annika undertook training at the prestigious St John’s Institute of Dermatology London, followed by further sub-specialty training in New York. Annika has a special interest in complex medical dermatology, including clinical and research […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.